At a glance
ClinicalIndex Comparison RecordN/ACompleted· 133 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of the Clinical Symptoms of the Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC).
In Brief
An observational study for Primary; Complex and 3 related conditions. Completed, enrolled 133 participants across 1 site.
Detailed Summary
Cohort CNC-PPNAD will be investigated with clinical, genetic, biological and imaging work-up every year during 3 years. Cohort L-MC will be investigated clinically at inclusion and a PERKAR1A genotype will be performed.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary; Complex, Pigmented Nodular Adrenocortical Disease, Primary, 1, Periorificial Lentiginosis, Cardiac Myxoma
CountriesFrance
CollaboratorsURC-CIC Paris Descartes Necker Cochin
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedApr 2008
Primary CompletionMay 2015
Study CompletionJan 2016
TodayJul 2026
First PostedApr 29, 2008
Enrollment StartJan 1, 2008
Primary CompletionMay 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 18.2 years ago